| Primary |
| Osteoporosis |
62.2% |
| Osteoporosis Postmenopausal |
8.2% |
| Osteopenia |
3.1% |
| Spinal Fracture |
3.1% |
| Collagen Disorder |
2.0% |
| Extraskeletal Ossification |
2.0% |
| Hepatic Cirrhosis |
2.0% |
| Hip Arthroplasty |
2.0% |
| Osteitis Deformans |
2.0% |
| Osteoporosis Prophylaxis |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Spinal Column Stenosis |
2.0% |
| Asthma |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Dystrophic Calcification |
1.0% |
| Epilepsy |
1.0% |
| Neck Pain |
1.0% |
| Steroid Therapy |
1.0% |
| Zinc Deficiency |
1.0% |
|
| Oesophageal Carcinoma |
10.3% |
| Cerebrovascular Accident |
7.7% |
| Osteonecrosis |
7.7% |
| Primary Sequestrum |
7.7% |
| Stress Fracture |
7.7% |
| Tooth Extraction |
7.7% |
| Femur Fracture |
5.1% |
| Hypercalcaemia |
5.1% |
| Pain In Extremity |
5.1% |
| Thrombocytopenia |
5.1% |
| Tooth Disorder |
5.1% |
| Vasculitis |
5.1% |
| Acute Myocardial Infarction |
2.6% |
| Arthralgia |
2.6% |
| Blindness Unilateral |
2.6% |
| Blood 25-Hydroxycholecalciferol Decreased |
2.6% |
| Cholelithiasis |
2.6% |
| Dysphagia |
2.6% |
| Dyspnoea |
2.6% |
| Exposed Bone In Jaw |
2.6% |
|
| Secondary |
| Osteoporosis |
64.5% |
| Osteopenia |
7.0% |
| Osteoporosis Postmenopausal |
4.5% |
| Drug Use For Unknown Indication |
3.5% |
| Rheumatoid Arthritis |
2.5% |
| Constipation |
2.0% |
| Crohn's Disease |
2.0% |
| Hepatitis |
2.0% |
| Hypothyroidism |
2.0% |
| Routine Health Maintenance |
2.0% |
| Systemic Lupus Erythematosus |
2.0% |
| Metastases To Bone |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Bladder Spasm |
1.0% |
| Nausea |
1.0% |
| Dementia |
0.5% |
| Peptic Ulcer |
0.5% |
|
| Femur Fracture |
21.7% |
| Tooth Disorder |
13.0% |
| Vomiting |
8.7% |
| Toothache |
6.5% |
| Trismus |
6.5% |
| Urinary Tract Infection |
6.5% |
| Impaired Healing |
4.3% |
| Weight Decreased |
4.3% |
| Wrist Fracture |
4.3% |
| Asthenia |
2.2% |
| Bone Pain |
2.2% |
| Depressed Level Of Consciousness |
2.2% |
| Gastrointestinal Disorder |
2.2% |
| Hiatus Hernia |
2.2% |
| Hyperparathyroidism Primary |
2.2% |
| Joint Instability |
2.2% |
| Myelodysplastic Syndrome |
2.2% |
| Nephrolithiasis |
2.2% |
| Non-hodgkin's Lymphoma |
2.2% |
| Osteomyelitis |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
38.1% |
| Rheumatoid Arthritis |
20.9% |
| Osteoporosis |
11.2% |
| Product Used For Unknown Indication |
6.7% |
| Cardiac Pacemaker Replacement |
3.6% |
| Osteopenia |
2.6% |
| Osteoporosis Prophylaxis |
2.5% |
| Hypertension |
2.5% |
| Juvenile Arthritis |
1.5% |
| Mitral Valve Disease Mixed |
1.2% |
| Constipation |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Prophylaxis |
1.1% |
| Sjogren's Syndrome |
1.1% |
| Systemic Lupus Erythematosus |
1.1% |
| Gastritis Prophylaxis |
0.9% |
| Medical Diet |
0.8% |
| Depression |
0.7% |
| Post-traumatic Stress Disorder |
0.7% |
| Hyperlipidaemia |
0.6% |
|
| Metastatic Neoplasm |
8.5% |
| Rheumatoid Arthritis |
8.5% |
| Breast Cancer |
5.9% |
| Lung Infection |
5.9% |
| Weight Increased |
5.9% |
| Death |
5.1% |
| Prostate Cancer |
5.1% |
| Pyrexia |
5.1% |
| Sepsis |
5.1% |
| Weight Decreased |
5.1% |
| Cardiac Failure |
4.2% |
| Chronic Obstructive Pulmonary Disease |
4.2% |
| Hypoaesthesia Facial |
4.2% |
| Myocardial Infarction |
4.2% |
| Pleural Effusion |
4.2% |
| Urinary Tract Infection |
4.2% |
| Vomiting |
4.2% |
| Anaemia |
3.4% |
| Oedema Peripheral |
3.4% |
| Renal Failure |
3.4% |
|
